Search

Your search keyword '"Bouvier, Nancy"' showing total 48 results

Search Constraints

Start Over You searched for: Author "Bouvier, Nancy" Remove constraint Author: "Bouvier, Nancy" Publisher american association for cancer research (aacr) Remove constraint Publisher: american association for cancer research (aacr)
48 results on '"Bouvier, Nancy"'

Search Results

1. Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma

2. Data from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

3. Supplementary Table 1 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

4. Data from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

5. Supplementary Figure 1 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

6. Supplementary Table 2 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

7. Data from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

8. Supplementary Figure Legends from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

9. Supplementary Figure 2 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

10. Data from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

11. Supplementary Figure 3 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

12. Figure S1 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

13. Supplementary Figure Legends from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

14. Supplementary Figure 1 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

15. Supplementary Figure 2 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

16. Figure S2 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

17. Data from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

18. Supplementary Tables S1-S10 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

19. Supplementary Figure Legends from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

20. Figure S3 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

21. Figure S4 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

22. Figure S4 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

23. Supplementary Figure 3 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

24. Figure S2 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

25. Figure S1 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

26. Figure S3 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

27. Supplementary Figure 4 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

28. Supplementary Figure 4 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

29. Supplementary Figure Legends from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

30. Figure S1 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

31. Supplementary Table 2 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

32. Figure S2 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

33. Supplementary Tables S1-S10 from EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

34. Figure S2 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

35. Supplementary Table 1 from Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

36. Figure S1 from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

37. Data from Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

38. Supplemental Data (Figures and Tables) from DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma

39. Supplemental Data (Figures and Tables) from DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma

40. Abstract B022: Subclonal somatic copy number alterations emerge and dominate in relapsed/refractory osteosarcoma

42. Abstract 704: Development of a patient-derived xenograft (PDX) modeling program to enable pediatric precision medicine

43. Comprehensive Molecular Profiling of Desmoplastic Small Round Cell Tumor

45. EGFR and MET Amplifications Determine Response to HER2 Inhibition in ERBB2-Amplified Esophagogastric Cancer

46. Genetic Predictors of Response to Systemic Therapy in Esophagogastric Cancer

47. DNA Damage Response and Repair Gene Alterations Are Associated with Improved Survival in Patients with Platinum-Treated Advanced Urothelial Carcinoma

48. Abstract CT001: Neratinib in HER2 or HER3 mutant solid tumors: SUMMIT, a global, multi-histology, open-label, phase 2 "basket" study

Catalog

Books, media, physical & digital resources